TY - JOUR
T1 - Quality of clinical practice guidelines in Japan remains low
T2 - A cross-sectional meta-epidemiological study
AU - Kataoka, Yuki
AU - Anan, Keisuke
AU - Taito, Shunsuke
AU - Tsujimoto, Yasushi
AU - Kurata, Yasuko
AU - Wada, Yoshitaka
AU - Maruta, Masaki
AU - Kanaoka, Koshiro
AU - Oide, Shiho
AU - Takahashi, Sei
AU - Nango, Eishu
N1 - Funding Information:
Yasushi Tsujimoto received a research grant from the Systematic Review Workshop Peer Support Group, Pfizer Health Research Foundation for other research purposes. Yasuko Kurata, Yoshitaka Wada, Masaki Maruta, Koshiro Kanaoka, Shiho Oide, Sei Takahashi and Eishu Nango: none known. Yuki Kataoka, Keisuke Anan, Yasushi Tsujimoto, Shunsuke Taito, and Sei Takahashi have been involved in the development of CPGs that were not included in this study. Yuki Kataoka, Keisuke Anan, Yasushi Tsujimoto, Shunsuke Taito, and Yoshitaka Wada manage an online community to conduct systematic reviews (SRWS-PSG). Yasuko Kurata, Masaki Maruta, Koshiro Kanaoka, Shiho Oide, and Sei Takahashi are the participants of the online community. Eishu Nango is a member of the GRADE working group and has been involved in the development of the Japanese clinical practice guideline for epilepsy 2018 and the Japanese clinical practice guideline for Parkinson disease 2018, which were included in this study and other CPGs that were not included in this study as methodologists
Funding Information:
Yuki Kataoka received a research grant from the Systematic Review Workshop Peer Support Group, the Japan Osteoporosis Foundation, and Yasuda Memorial Medical Foundation for other research purposes. Keisuke Anan received a research grant from Systematic Review Workshop Peer Support Group for other research purposes. Shunsuke Taito received a research grant from the Systematic Review Workshop Peer Support Group for other research purposes.
Publisher Copyright:
© 2021 Elsevier Inc.
PY - 2021/10
Y1 - 2021/10
N2 - Objectives: We aimed to evaluate the characteristics, quality, and related factors of the Japanese Clinical Practice Guidelines (CPGs) published in recent years. Study design and setting: In this cross-sectional, meta-epidemiological study, we conducted a Google search for CPGs published by 30 Japanese medical societies that are the basis for training specialties between 2018 and 2019. We used the Appraisal of Guidelines for Research & Evaluation II (AGREE II) tool and the Reporting Items for practice Guidelines in HealThcare (RIGHT) statement to evaluate the quality. Results: We included 53 systematic review-based CPGs. The median score was 0.54 (IQR, 0.38-0.62) for Stakeholder involvement, 0.57 (IQR, 0.51–0.66) in Rigor of development, 0.33 (IQR 0.21–0.46) in Applicability, and 0.63 (IQR 0.46–0.73) in Editorial independence. The number of guideline developers/clinical question ratio (odds ratio [OR]: 4.14, 95% confidence interval [CI]: 1.97, 8.70) and the adopted guideline development methods (OR: 3.69, 95% CI: 1.14, 12.0) were significantly related to the Rigor of development. Conclusion: The quality of Japanese CPGs published in recent years remains low. Our study suggests that increasing contributors and adopting the latest guideline development methods at the beginning of the project may improve the quality of the Japanese CPGs.
AB - Objectives: We aimed to evaluate the characteristics, quality, and related factors of the Japanese Clinical Practice Guidelines (CPGs) published in recent years. Study design and setting: In this cross-sectional, meta-epidemiological study, we conducted a Google search for CPGs published by 30 Japanese medical societies that are the basis for training specialties between 2018 and 2019. We used the Appraisal of Guidelines for Research & Evaluation II (AGREE II) tool and the Reporting Items for practice Guidelines in HealThcare (RIGHT) statement to evaluate the quality. Results: We included 53 systematic review-based CPGs. The median score was 0.54 (IQR, 0.38-0.62) for Stakeholder involvement, 0.57 (IQR, 0.51–0.66) in Rigor of development, 0.33 (IQR 0.21–0.46) in Applicability, and 0.63 (IQR 0.46–0.73) in Editorial independence. The number of guideline developers/clinical question ratio (odds ratio [OR]: 4.14, 95% confidence interval [CI]: 1.97, 8.70) and the adopted guideline development methods (OR: 3.69, 95% CI: 1.14, 12.0) were significantly related to the Rigor of development. Conclusion: The quality of Japanese CPGs published in recent years remains low. Our study suggests that increasing contributors and adopting the latest guideline development methods at the beginning of the project may improve the quality of the Japanese CPGs.
UR - http://www.scopus.com/inward/record.url?scp=85111256570&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85111256570&partnerID=8YFLogxK
U2 - 10.1016/j.jclinepi.2021.06.025
DO - 10.1016/j.jclinepi.2021.06.025
M3 - Article
C2 - 34217818
AN - SCOPUS:85111256570
VL - 138
SP - 22
EP - 31
JO - Journal of Chronic Diseases
JF - Journal of Chronic Diseases
SN - 0895-4356
ER -